"We still believe the most likely outcome is slow growth and firm inflation: Not a recession, but a backdrop where the adverse effects of trade and immigration controls on growth outweigh the boost from deregulation and fiscal largesse," Morgan Stanley strategist Michael Zezas wrote.

In a crucial week for the U.S. economy, Wall Street reacted in mixed fashion to President Trump’s deal with the European Union, just five days before steep tariffs were set to go into effect on one of the United States’ most valuable trading partners.

The stock market didn't make big moves Monday, but it did set some new records in response to the Trump administration's trade deal with Europe. Here's what some on Wall Street are saying about the latest developments: “The market is really quite extended,

Among the strongest performers, Thermo Fisher Scientific rose 12%, topping the leaderboard for large-cap stocks, followed by T-Mobile US, up 9%.

Wall Street analysts are betting hard against Trump’s trade agenda surviving in court. The lawsuits stacking up across the country are gunning straight for the legal base of his tariff powers. And they’re not just hoping to overturn a few decisions;

President Donald Trump’s vows to roll out punishing new tariffs on Aug. 1 have barely made a ripple with investors who are convinced he’ll once again back down. But at the White House, officials insist they’re serious this time.

While some Wall Street companies are clearly rallying thanks to President Donald Trump’s policies, the same can’t be said for Main Street, according to a chart from BofA Global Research strategists, led by Michael Hartnett.

Attorney General Pam Bondi and Deputy Attorney General Todd Blanche told Donald Trump that his name appears in Epstein investigation files.